DLX6 and endometrial cancer: Initially, analysis from GEPIA database (http://gepia.cancer‐pku.cn/index.html) showed that DLX6‐AS1 was highly expressed in endometrial cancer (Figure 1A), which was further confirmed by RT‐qPCR of the patient samples (Figure 1B).